Healthcare - Events

Kick off 2026 and set the tone for the year at 18th Annual Pre-Filled Syringes and Injectable Drug Devices Conference! Join us in London on the 13th - 15th January 2026 where we will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program. As part of SAE's leading Injectable Drug Delivery Series, the event features: - Pre-Conference Focus Day: PFS Design for Enhanced Drug Delivery- Two-Day Main Conference: Morning keynote plenaries and afternoon parallel topic streams addressing the industry's most pressing challenges, including:- Large-Volume Drug Delivery Solutions- Sus…

The Pharma and Biotech Patent Litigation Track at the Patent Litigation Europe Summit 2026 is the leading European forum for life sciences IP counsel and litigators to benchmark enforcement strategies, navigate evolving UPC case law, and prepare for the next wave of biosimilar and generic challenges. Taking place on 20–21 January 2026 at the Beurs van Berlage in Amsterdam, the track continues the legacy of the Pharma and Biotech Patent Litigation Summit while introducing a broader cross-sector environment under the newly rebranded Patent Litigation Europe umbrella. This stream remains the anchor event for the life sciences audience, attracting around 600 attendees, with an exceptional 45% in-house counsel ratio from leading pharmaceutical innovators, biotechs, generics and biosimilar devel…

Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…

Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…

Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside. As the only event uniting the entire RNAi ecosystem from discovery and complex chemistry to clinical development and CMC, this Summit provides an unparalleled platform to tackle the field's most pressing challenge: delivery beyond the liver. This is your unique opportunity to join 80+ senior leaders from pharma and biotech to gain the data-driven insights and high-value connections needed to overcome stability challenges, de-risk clinical translation,…

mRNA is no longer just a headline, it's transforming medicine. From BioNTech's acquisition of CureVac to the EMA's and MHRA's latest guidance on mRNA product development, and even the world's first personalised CRISPR therapy for Baby KJ, the field has reached a new level of stability while opening doors to revolutionary therapeutic and gene editing applications. Returning for its fifth year, the mRNA-Based Therapeutics Summit Europe gives you the insights and connections to turn these breakthroughs into action. The new Gene Editing Focus Day highlights how mRNA enables safer, transient editing strategies, while addressing regulatory and translational challenges. Hear directly from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others about clinical readiness and delivery innovations…

Enabling Rapid Target Selection, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent, Selective and Safer Cures for Cancer and Beyond. Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic. If you’re looking to lead the way in the…

Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel DDR targets like ATR, CHK1/2, DNA-PK, and WEE1, alongside smarter biomarker strategies and combination approaches. This year's summit is your opportunity to stay ahead of the curve. Across three content-rich days, you'll uncover translational breakthroughs, hear from biotech innovators and academic pioneers, and gain strategic insights to overcome resistance, enhance selectivity, and accelerate clinical success. With the DDR landscape rapidly expanding, now is the time to connect, collaborate, and shape the future of targeted o…

For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market. Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative. The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translatio…

Inspection Readiness 360 unites clinical operations, TMF, quality, and regulatory leaders for two days of expert insights, case studies, and strategies to ensure your organization is inspection-ready in any environment. Date and Time: On Tue, 27 Jan 2026 09:00 - Wed, 28 Jan 2026 17:00 Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States Category: Conferences | Science, Health and Medicine

Discover how AI is transforming medical affairs at the 5th Annual AI in Medical Affairs, taking place January 27-28, 2026, in Philadelphia, PA.Join pharmaceutical, biotech, and medical device leaders to explore real-world AI applications, innovative strategies, and compliance best practices.Engage in expert panels, case studies, and networking to gain actionable insights that enhance content creation, optimize field medical operations, and drive impactful stakeholder engagement. Time: 9:00 AM - 5:00 PM Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States Category: Conferences | Science, Health and Medicine

The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanemab and Donanemab, the field needs to navigate the move towards disease-modifying therapeutics. Capitalizing on the surge of innovation across new targets, lessons learned from clinical setbacks, groundbreaking progress in blood-based diagnostics, and more, the 14th Alzheimer’s and Parkinson’s Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory.   URLs:Tickets: https://go.evvnt.com/3259347-2?pid=185&n…

Join us at the forefront of innovation at the Marcus Evans 15th Edition R&D and Innovation Excellence Forum, where industry leaders will explore the latest strategies to optimise investments, streamline decision-making, and accelerate transformation in R&D and Innovation. Dive into practical insights on balancing portfolios, maximising ROI, and aligning innovation with market demands. This event is your gateway to understanding how to drive efficiency, foster cross-functional collaboration, and refine R&D and Innovation processes to stay ahead in an increasingly competitive landscape. Don't miss out on this opportunity to empower your R&D team with the tools and knowledge to thrive in a rapidly evolving market. Key Topics Include:  Achieving Operational Excellence in…

This highly interactive two-day course uses real life examples and explores proven techniques for reducing costs, usually by two-thirds, associated with implementing, and maintaining computer systems in regulated environments. It details the requirements for Part 11 and Annex 11: SOPs, software product features, infrastructure qualification, and validation. The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation. Understand the specific requirements associated with local and SaaS/cloud hosting solutions. Nearly every computerized system used in laboratory, clinical, manufacturing settings and in the quality process has to be validated. Parti…

Critical Issues America2026 Annual Conference - February 6-7, 2026We invite you to attend our annual CRITICAL ISSUES america (CIA) meeting. The meeting will help participants to identify and manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal and juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta. CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease. The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professiona…

Innovating Novel Combination Therapies and Maximising Preclinical and Clinical Development to Improve Glioblastoma Targeting and Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in NeedThe glioblastoma drug development space has been energized by Merck's acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs. Looking ahead to 2026, it's crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress. Join us for a definitive, 3-day summit designed to accelerate progress. With groundbreaking content and six deep-dive workshops, you'll connec…

In this two day workshop conference you will learn the requirements and expectations of major health care regulators that are applicable to "virtual" companies. You will learn how to diagnose your company's needs based on which GMP and GCP-governed operations you retain and which you outsource; what the current expectations and best industry practices are for selecting, qualifying and monitoring your contractors to ensure they are meeting your requirements; and how to build a quality system framework that is not excessive for your current needs, but has the structure and integration to "grow with you" as the scope your operations change in the coming months and years. Learning Objectives: Participants in this seminar will: Understand the GMP and GCP requirements all virtual companies must…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar This seminar bridges that gap. Designed specifically for non-statisticians, it provides a clear, practical introduction to biostatistics without overwhelming you with mathematics. You’ll learn the “why” behind the numbers, gain tools to spot meaningful findings, and avoid being misled by misused statistics. By the end of the program, you’ll be able to read statistical reports with confidence, communicate findings to colleagues and stakeholders, and make better data-driven decisions that can shape the future of clinical and biotech innovation. Why Should You Attend: In the world of clinical research and biotechnology, numbers carry weight. A single statistical finding can influence whether a project moves forward, a regulat…

About NEURO 2026 We are delighted to welcome you to the 4th European Congress of Neurology and Neuropsychiatry (Earn CME/CPD Credits) which will take place on February 23-24, 2026 in Paris, France. Neurology Conference 2026 will bring together leading neurologists, neuropsychiatrists, researchers, and healthcare professionals from around the globe to discuss the latest developments in neurology, psychiatry, and brain health.   Building upon the resounding success of the 2nd European Congress held in London, UK and 3rd European Congress held in Amsterdam, Netherlands we are eager to continue the tradition of fostering collaboration, knowledge exchange, and innovation in the field of neurology and neuropsychiatry. Amsterdam, with its rich history, cult…